DEVICE CATEGORY · MZO
Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus
FDA classification: Microbiology. Device class 2.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Anti-HCV NextK262156 | ABBOTT LABORATORIES | 510(k) clearance | Sep 23, 2026 | FDA |
Source information
Follow the FDA links to view the original records.
